Sinovac Biotech Ltd. (SVA) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

Sinovac Biotech Ltd. (SVA) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $464.9M, listed on NASDAQ, employing roughly 1,959 people, carrying a beta of 0.00 to the broader market. Sinovac Biotech Ltd. Led by Wei Dong Yin, public since 2003-09-26.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for SVA as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →